EP3090730
Töflur sem innihalda Eltrombopag Olanmine
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.8.2007EP published:
10.4.2024EP application number:
15199469.6
EP translation filed:
12.6.2024Grant published:
15.7.2024EPO information:
European Patent Register
Max expiry date:
31.7.2027Expiry date:
31.7.2026Next due date:
31.8.2026
Title in English:
TABLETS COMPRISING ELTROMBOPAG OLAMINELanguage of the patent:
English
Timeline
Today
1.8.2007EP application
10.4.2024EP Publication
12.6.2024Translation submitted
15.7.2024Registration published
31.7.2026Expires
Owner
Name:
Novartis Pharma AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
KAPSI, Shivakumar, G.Address:
Kind Of Prussia, Pennsylvania 19406, US
Name:
Muller, Francis, X.Address:
King Of Prussia, Pennsylvania 19406, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
915761 PDate:
3.5.2007Country:
US
Number:
947731 PDate:
3.7.2007Country:
US
Classification
Categories:
A61K 9/14, A61K 9/54, A61K 47/34, A61P 7/06, A61K 31/4152, A61K 47/26, C07D 231/46, A61K 9/20
Annual fees
Number
Paid
Expires
Payer
Number: 18
Paid: 12.6.2024
Expires: 31.7.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 29.7.2025
Expires: 31.7.2026
Payer: Árnason Faktor ehf.